MLchartDataset catalogue

mesalamine

Term · Oncology and biomedicine · MLC-T-ONC-015101

An agent derived from sulfasalazine, an antiinflammatory agent. Mesalamine may reduce inflammation through inhibition of cyclooxygenase and prostaglandin production. Following rectal or oral administration, only a small amount of mesalamine is absorbed; the remainder, acting topically, reduces bowel inflammation, diarrhea, rectal bleeding and stomach pain.

Table 1. Record
IdentifierMLC-T-ONC-015101
FieldOncology and biomedicine
Abbreviation5-ASA
Synonymsmesalazine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015101",
  "term": "mesalamine",
  "field": "Oncology and biomedicine",
  "definition": "An agent derived from sulfasalazine, an antiinflammatory agent. Mesalamine may reduce inflammation through inhibition of cyclooxygenase and prostaglandin production. Following rectal or oral administration, only a small amount of mesalamine is absorbed; the remainder, acting topically, reduces bowel inflammation, diarrhea, rectal bleeding and stomach pain.",
  "abbreviation": "5-ASA",
  "synonyms": [
    "mesalazine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/mesalamine/"
}

Record 10,873 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.